Literature DB >> 3041996

Cardiovascular effects of neuropeptide Y.

B Waeber1, J F Aubert, R Corder, D Evéquoz, J Nussberger, R Gaillard, H R Brunner.   

Abstract

Neuropeptide Y (NPY) is present in the brain, the adrenal medulla, and peripheral sympathetic nerves. This peptide is released together with catecholamines during sympathoadrenal activation. It possesses direct vasoconstrictor properties that are not dependent on simultaneous adrenergic activation. Moreover, it potentiates the vascular effect of several stimulatory substances and may contribute to the modulation of blood pressure responsiveness under a number of circumstances. NPY may also be indirectly involved in the control of blood pressure through regulating the release of hormones with well-established actions on the cardiovascular system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3041996     DOI: 10.1093/ajh/1.2.193

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  3 in total

1.  Role of G-protein beta gamma subunits in the augmentation of P2Y2 (P2U)receptor-stimulated responses by neuropeptide Y Y1 Gi/o-coupled receptors.

Authors:  L A Selbie; N V King; J M Dickenson; S J Hill
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

2.  Effects of phosphorothioated neuropeptide Y Y1-receptor antisense oligodeoxynucleotide in conscious rats and in human vessels.

Authors:  X Y Sun; X H Zhao; D Erlinge; L Edvinsson; B Fallgren; C Wahlestedt; T Hedner
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

3.  Localization and coexistence of atrial natriuretic peptide (ANP) and neuropeptide Y (NPY) in vertebrate adrenal chromaffin cells immunoreactive to TH, DBH and PNMT.

Authors:  M Wolfensberger; W G Forssmann; M Reinecke
Journal:  Cell Tissue Res       Date:  1995-05       Impact factor: 5.249

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.